Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.

Skip to main content

Table 7 Comorbidity and ADR

From: Incidence of adverse reaction of drugs used in COVID-19 management: a retrospective, observational study

Comorbidity

Number of patients

Patients with ADR

P value#

Cancer

4

3 (75.0%)

0.006

Obesity

7

5 (71.4%)

0.001

Chronic kidney disease

38

19 (50.0%)

< 0.001

Cardiovascular diseases

58

23 (39.7%)

< 0.001

Hypertension

249

75 (30.1%)

< 0.001

Diabetes mellitus

157

46 (29.3%)

0.002

Chronic obstructive lung disease

4

1 (25.0%)

0.814

Asthma

47

10 (21.3%)

0.862

  1. Patients with ADR are reported as n (%), where % is calculated by patients with ADR/number of patients
  2. #Analysed with Chi-square (X2) test